Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Becton Dickinson’s Bard Wins Patent Trial on Implanted Ports

Nov. 23, 2022, 7:30 PM

AngioDynamics Inc.‘s implantable ports infringe patents owned by Becton Dickinson and Co.’s C.R. Bard unit, a federal jury in Delaware ruled.

The result, which AngioDynamics announced in a regulatory filing on Wednesday, is a win for Bard in a suit it filed nearly eight years ago and that it lost in 2019 before the Federal Circuit revived the case in November 2020.

The docket in the US District Court for the District of Delaware doesn’t yet reflect the verdict, which jurors returned Tuesday afternoon. The regulatory filing didn’t include details of the jury’s findings as to specific patents.

The ...